No Data
No Data
Mural Oncology Plc Elects Directors at Annual Meeting
Mural Oncology Announces Number of Relevant Securities in Issue
Mural Oncology | 10-Q: Q1 2025 Earnings Report
Mural Oncology Plc Opening Position Disclosure Under Irish Takeover Rules
FORM 8.1(a) & (B) - Mural Oncology Plc
Morgan Stanley Maintains Mural Oncology(MURA.US) With Hold Rating